[DOI] [PMC free article] [PubMed] [Google Scholar] 1561.Dorman JS, Steenkiste AR, Foley TP, et al
Others add complementary therapies
Studies in the journal of Diabetes, Obesity & Metabolism dating back to 2017 have shown that the risk of gastrointestinal problems from Ozempic was higher when the drug was prescribed at higher doses, for longer durations, and when the drug was used for weight loss
Most GLP-1 medications including Ozempic (semaglutide), Wegovy, Mounjaro (tirzepatide), and Zepbound can be taken with: oral antihistamines (cetirizine, loratadine, fexofenadine) nasal steroid sprays (fluticasone, mometasone) asthma inhalers leukotriene modifiers (montelukast) allergy drops (SLIT) allergy shots decongestants (with some caution) Current AAAAI and NIH guidance show no known harmful interactions between these drug classes
The most common side effects reported during clinical trials include: Nausea Vomiting Diarrhea Constipation Abdominal Pain Most side effects are mild and tend to diminish as the body adjusts to the medication
Babu MR, Vishwas S, Khursheed R, Harish V, Sravani AB, Khan F, Alotaibi B, Binshaya A, Disouza J, Kumbhar PS, Patravale V, Gupta G, Loebenberg R, Arshad MF, Patel A, Patel S, Dua K, Singh SK
